This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://linked.opendata.cz/resource/drugbank/drug/DB08182/identifier/drugbank/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08182/identifier/chemspider/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/drug/DB08182/identifier/pdb/
n4http://linked.opendata.cz/resource/drugbank/property/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08182/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB08182/identifier/pubchem-substance/

Statements

Subject Item
n2:DB08182
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n11:DB08182 n13:DB08182
dcterms:title
4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine
adms:identifier
n6:DB08182 n7:MHR n8:22377653 n9:23727982 n12:99444653
n3:IUPAC-Name
n4:271B3F4A-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B3F50-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B3F4F-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B3F4C-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B3F4D-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B3F4E-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B3F48-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B3F46-363D-11E5-9242-09173F13E4C5 n4:271B3F49-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B3F47-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B3F56-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B3F57-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B3F51-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B3F52-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B3F54-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B3F53-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B3F55-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B3F5C-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B3F5E-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B3F5F-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B3F5B-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B3F5A-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B3F5D-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B3F4B-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B3F58-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B3F59-363D-11E5-9242-09173F13E4C5